Health Care & Life Sciences » Biotechnology | Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$90.72 M
Shares Outstanding
21.7 M
Public Float
18.03 M


1325 Avenue of Americas
New York New Jersey 10019
United States
Employees -
Updated 07/08/2019
Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ.


View All

Jerold Chun
Uri Yablonka
Director, Chief Business Officer & Executive VP